Tangram Therapeutics Announces Progression to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial of TGM-312 and Appointment of Dr Sonya Montgomery as Chief Development Officer

TGM-312, an investigational GalOmic siRNA targeting SLC25A5, has a dual mode of action that directly impacts inflammation and steatosis, the key drivers of MASH and other chronic liver conditions. The ...
Yahoo Finance

Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine

LONDON, March 05, 2026 (GLOBE NEWSWIRE) -- Tangram Therapeutics ('Tangram'), a company committed to uniting computation and RNAi to make better medicines faster, today announced the dosing of the ...
Yahoo Finance

TGM MOURNS DEATH OF CO-FOUNDER AND MANAGING PRINCIPAL STEVEN C. MACY

NEW YORK, Dec. 9, 2024 /PRNewswire/ -- It is with profound sadness that TGM mourns the death of its Co-founder and Managing Principal, Steven C. Macy (1949-2024). Steve, real estate executive, husband ...
Hosted on MSN

Tangram submits application to MHRA for TGM-312 Phase I/II clinical trial

Tangram Therapeutics has submitted a clinical trial application (CTA) to the Medicines and Healthcare products Regulatory Agency (MHRA) to begin a Phase I/II trial of TGM-312. TGM-312 is an ...
Guru3D.com

Thermaltake introduces TGM-I27FQ and TGM-V32CQ Gaming Monitors

Thermaltake has introduced two new gaming monitor models: the TGM-I27FQ and the TGM-V32CQ. The TGM-I27FQ, with a QHD resolution (2560x1440), is tailored towards professional gaming use. It ...
PCGamesN

Thermaltake TGM-V32CQ review

Mid-tier gaming monitors can afford compromises, but with 165Hz and a QHD panel, this Thermaltake monitor should be better for the price. It's rare to come away from testing a product feeling ...